Portal de investigação
Patient-centered digital biomarkers for allergic respiratory diseases and asthma: The ARIA-EAACI approach - ARIA-EAACI Task Force Report
Data de publicação:
Autores da FMUP
Participantes de fora da FMUP
- Bousquet, J
- Shamji, MH
- Anto, JM
- Schünemann, HJ
- Canonica, GW
- Jutel, M
- Del Giacco, S
- Zuberbier, T
- Pfaar, O
- Klimek, L
- Czarlewski, W
- Bedbrook, A
- Ansotegui, IJ
- Bosnic-Anticevich, S
- Braido, F
- Loureiro, CC
- Gemicioglu, B
- Haahtela, T
- Kulus, M
- Kuna, P
- Kupczyk, M
- Matricardi, PM
- Regateiro, FS
- Samolinski, B
- Sofiev, M
- Toppila-Salmi, S
- Valiulis, A
- Ventura, MT
- Barbara, C
- Bergmann, KC
- Bewick, M
- Blain, H
- Bonini, M
- Boulet, LP
- Bourret, R
- Brusselle, G
- Brussino, L
- Buhl, R
- Cardona, V
- Casale, T
- Cecchi, L
- Charpin, D
- Cherrez-Ojeda, I
- Chu, DK
- Cingi, C
- Costa, EM
- Cruz, AA
- Devillier, P
- Dramburg, S
- Fokkens, WJ
- Gotua, M
- Heffler, E
- Ispayeva, Z
- Ivancevich, JC
- Joos, G
- Kaidashev, I
- Kraxner, H
- Kvedariene, V
- Larenas-Linnemann, DE
- Laune, D
- Lourenço, O
- Louis, R
- Makela, M
- Makris, M
- Maurer, M
- Melen, E
- Micheli, Y
- Morais-Almeida, M
- Mullol, J
- Niedoszytko, M
- O'Hehir, R
- Okamoto, Y
- Olze, H
- Papadopoulos, NG
- Papi, A
- Patella, V
- Pétré, B
- Pham-Thi, N
- Puggioni, F
- Quirce, S
- Roche, N
- Rouadi, PW
- Sa-Sousa, A
- Sagara, H
- Sastre, J
- Scichilone, N
- Sheikh, A
- Sova, M
- Ulrik, CS
- Taborda-Barata, L
- Todo-Bom, A
- Torres, MJ
- Tsiligianni, I
- Usmani, OS
- Valovirta, E
- Vasankari, T
- Wallace, D
- Waserman, S
- Zidarn, M
- Yorgancioglu, A
- Zhang, L
- Chivato, T
- Ollert, M
Unidades de investigação
Abstract
Biomarkers for the diagnosis, treatment and follow-up of patients with rhinitis and/or asthma are urgently needed. Although some biologic biomarkers exist in specialist care for asthma, they cannot be largely used in primary care. There are no validated biomarkers in rhinitis or allergen immunotherapy (AIT) that can be used in clinical practice. The digital transformation of health and health care (including mHealth) places the patient at the center of the health system and is likely to optimize the practice of allergy. Allergic Rhinitis and its Impact on Asthma (ARIA) and EAACI (European Academy of Allergy and Clinical Immunology) developed a Task Force aimed at proposing patient-reported outcome measures (PROMs) as digital biomarkers that can be easily used for different purposes in rhinitis and asthma. It first defined control digital biomarkers that should make a bridge between clinical practice, randomized controlled trials, observational real-life studies and allergen challenges. Using the MASK-air app as a model, a daily electronic combined symptom-medication score for allergic diseases (CSMS) or for asthma (e-DASTHMA), combined with a monthly control questionnaire, was embedded in a strategy similar to the diabetes approach for disease control. To mimic real-life, it secondly proposed quality-of-life digital biomarkers including daily EQ-5D visual analogue scales and the bi-weekly RhinAsthma Patient Perspective (RAAP). The potential implications for the management of allergic respiratory diseases were proposed.
© 2023 The Authors. Allergy published by European Academy of Allergy and Clinical Immunology and John Wiley & Sons Ltd.
Dados da publicação
- ISSN/ISSNe:
- 0105-4538, 1398-9995
- Tipo:
- Review
- Páginas:
- 1758-1776
- DOI:
- 10.1111/all.15740
- Link para outro recurso:
- www.scopus.com
ALLERGY Wiley-Blackwell Publishing Ltd
Citações Recebidas na Scopus: 12
Documentos
- Não há documentos
Filiações
Keywords
- apps; ARIA; digital health; EAACI; rhinitis
Campos de estudo
Proyectos asociados
Prevalence and Characterisation of Asthma Patients According to Disease Severity in Portugal (EPI-ASTHMA) - NCT05169619
Investigador Principal: João de Almeida Lopes da Fonseca
Estudo Clínico Observacional (EPI-ASTHMA) . AstraZeneca . 2021
Effect of a Mobile App on Improving Asthma Control in Adolescents and Adults With Persistent Asthma: A Pilot Randomized Multicentre, Superiority Clinical Trial (mINSPIRERS) - NCT05129527
Investigador Principal: João de Almeida Lopes da Fonseca
Ensaio Clínico Académico (mINSPIRERS) . 2021
Utilização em estudos observacionais do Registo de Asma Grave Portugal.
Investigador Principal: João de Almeida Lopes da Fonseca
Estudo Observacional Académico (RAG) . 2020
Clinical Research Collaboration Severe Heterogenous Asthma Research collaboration, Patient-centered (CRC SHARP).
Investigador Principal: João de Almeida Lopes da Fonseca
Estudo Clínico Observacional (SHARP) . European Respiratory Society . 2021
Multidimensional phenotyping of severe asthma patients and its impact on disease control and therapeutic response - analysis from the Portuguese Severe Asthma Registry.
Investigador Principal: João de Almeida Lopes da Fonseca
Estudo Clínico Observacional (RAG-SPP-GSK) . SPPneumologia . 2022
BREATHE - An oBservational, pRimary data study to characterize severe AsThma pHenotypes and assEss disease burden across the EUCAN region.
Investigador Principal: João de Almeida Lopes da Fonseca
Estudo Clínico Observacional (RAG-AZ-BREATHE) . AstraZeneca . 2022
Seroprevalence of SARS-CoV-2 and assessment of epidemiologic determinants in Portuguese municipal workers
Investigador Principal: Bernardo Manuel De Sousa Pinto
Estudo Clínico Académico (SARS-CoV-2) . 2021
Efficiency in Spine Care ? Assessing outcomes and costs to inform healthcare improvement
Investigador Principal: João de Almeida Lopes da Fonseca
Estudo Clínico Académico . 2022
Use of secondary data, health technology assessment methods and economic modelling applied to penicillin allergy
Investigador Principal: João de Almeida Lopes da Fonseca
Estudo Clínico Académico . 2020
Using different data sources for the identification of asthma patients and those at high risk of adverse outcomes
Investigador Principal: João de Almeida Lopes da Fonseca
Estudo Clínico Académico . 2020
Phenotypes of Chronic Diseases of the Airways: Towards Multidimensional Data -Driven Profiling
Investigador Principal: João de Almeida Lopes da Fonseca
Estudo Clínico Académico . 2020
Citar a publicação
Bousquet J,Shamji MH,Anto JM,Schünemann HJ,Canonica GW,Jutel M,Del Giacco S,Zuberbier T,Pfaar O,Fonseca JA,Sousa B,Klimek L,Czarlewski W,Bedbrook A,Amaral R,Ansotegui IJ,Bosnic S,Braido F,Loureiro CC,Gemicioglu B,Haahtela T,Kulus M,Kuna P,Kupczyk M,Matricardi PM,Regateiro FS,Samolinski B,Sofiev M,Toppila S,Valiulis A,Ventura MT,Barbara C,Bergmann KC,Bewick M,Blain H,Bonini M,Boulet LP,Bourret R,Brusselle G,Brussino L,Buhl R,Cardona V,Casale T,Cecchi L,Charpin D,Cherrez I,Chu DK,Cingi C,Costa EM,Cruz AA,Devillier P,Dramburg S,Fokkens WJ,Gotua M,Heffler E,Ispayeva Z,Ivancevich JC,Joos G,Kaidashev I,Kraxner H,Kvedariene V,Larenas DE,Laune D,Lourenço O,Louis R,Makela M,Makris M,Maurer M,Melen E,Micheli Y,Morais M,Mullol J,Niedoszytko M,O'Hehir R,Okamoto Y,Olze H,Papadopoulos NG,Papi A,Patella V,Pétré B,Pham N,Puggioni F,Quirce S,Roche N,Rouadi PW,Sa A,Sagara H,Sastre J,Scichilone N,Sheikh A,Sova M,Ulrik CS,Taborda L,Todo A,Torres MJ,Tsiligianni I,Usmani OS,Valovirta E,Vasankari T,Vieira RJ,Wallace D,Waserman S,Zidarn M,Yorgancioglu A,Zhang L,Chivato T,Ollert M. Patient-centered digital biomarkers for allergic respiratory diseases and asthma: The ARIA-EAACI approach - ARIA-EAACI Task Force Report. Allergy. 2023. 78(7):p. 1758-1776. IF:12,400. (1).
